Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

21.67
Delayed Data
As of Sep 23
 +0.17 / +0.79%
Today’s Change
19.10
Today|||52-Week Range
46.24
-49.79%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Lanchbury Jerry S
Chief Scientific Officer
Sale10/28/201550,962$41.86$2.1M-49.53%
Marsh Richard M
Executive Vice President & General Counsel
Sale11/04/201535,000$44.50$1.6M-53.05%
Dreismann Heinrich
Director
Sale11/05/201530,000$44.44$1.3M-51.30%
Dreismann Heinrich
Director
Sale11/05/201530,000$44.44$1.3M-51.30%
Lanchbury Jerry S
Chief Scientific Officer
Buy10/28/201550,962$22.93$1.2M-49.53%
Dreismann Heinrich
Director
Buy11/05/201530,000$27.61$828.3K-51.30%
Marsh Richard M
Executive Vice President & General Counsel
Buy11/04/201535,000$22.93$802.6K-53.05%
Dreismann Heinrich
Director
Buy11/05/201530,000$25.39$761.7K-51.30%
King Gary A /myriad/
Executive Vice President
Sale4/06/201615,000$39.03$585.5K-44.52%
Henderson John Tannahill
Director
Sale9/09/201627,993$20.51$574.1K+6.75%
Page of 7